Cite
Feasibility of using a combination of staphylococcal superantigen‐like proteins 3, 7 and 11 in a fusion vaccine for Staphylococcus aureus.
MLA
Chan, Janlin Ying Hui, et al. “Feasibility of Using a Combination of Staphylococcal Superantigen‐like Proteins 3, 7 and 11 in a Fusion Vaccine for Staphylococcus Aureus.” Immunology & Cell Biology, vol. 102, no. 5, May 2024, pp. 365–80. EBSCOhost, https://doi.org/10.1111/imcb.12745.
APA
Chan, J. Y. H., Clow, F., Pearson, V., Langley, R. J., Fraser, J. D., & Radcliff, F. J. (2024). Feasibility of using a combination of staphylococcal superantigen‐like proteins 3, 7 and 11 in a fusion vaccine for Staphylococcus aureus. Immunology & Cell Biology, 102(5), 365–380. https://doi.org/10.1111/imcb.12745
Chicago
Chan, Janlin Ying Hui, Fiona Clow, Victoria Pearson, Ries J Langley, John D Fraser, and Fiona J Radcliff. 2024. “Feasibility of Using a Combination of Staphylococcal Superantigen‐like Proteins 3, 7 and 11 in a Fusion Vaccine for Staphylococcus Aureus.” Immunology & Cell Biology 102 (5): 365–80. doi:10.1111/imcb.12745.